📇 Rhumatologue · PERPIGNAN CEDEX · (66) · Libéral

M ANDRE-JEAN REMY

Pourquoi vous devez consulter ce praticien

5 raisons identifiées

Encadrant universitaire
Forme la prochaine génération de rhumatologues (2 thèses dirigées)
Praticien-chercheur
14 articles scientifiques publiés — formation continue solide
Expérience confirmée
30 ans d'exercice en rhumatologie — recul clinique solide
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
138.3 rhumatos / 100 000 hab. — département bien doté

Rhumatologue

📍 PERPIGNAN CEDEX (66)LibéralRPPS 10003229050

EnseignementExpérience confirmée

30ans d'exercice (thèse 1996)

📊 Reconnaissance scientifique : 8/100📝 44 articles publiés🇫🇷 Publications académiques françaises (5)🎓 2 thèses dirigées

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis

Clinical and experimental rheumatology · 2011

📚 42 citations🎯 RCR 1.34

Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone

Journal of hepatology · 2002

📚 17 citations🩺 Clinique

Middle-term mortality and re-bleeding after initial diverticular bleeding: A nationwide study of 365 mostly elderly French patients

United European gastroenterology journal · 2017

📚 13 citations🔓 Open Access📄 PDF gratuit ↗

Lire l'abstract Crossref ↓

Background and aimsThe aim of this study was to determine the mortality and re‐bleeding rates, and the risk factors involved, in a cohort of patients with previous diverticular bleeding (DB).MethodsIn 2007, data on 2462 patients with lower gastrointestinal (GI) bleeding were collected prospectively at several French hospitals. We studied the follow‐up of patients with DB retrospectively. The following data were collected: age, mortality rates and re‐bleeding rates, drug intake, surgery and comorbidities.ResultsData on 365 patients, including 181 women (mean age 83.6 ± 9.8 years) were available. The median follow‐up time was 3.9 years (IQR 25–75: 1.7–5.4). Of these, 148 patients died (40.5%). Among the 70 patients (19.2%) who had at least one re‐bleeding episode, nine died and three underwent surgical procedures. Anticoagulation and antiplatelet therapy was discontinued in 70 cases (19.2%).The independent risk factors contributing to mortality were age > 80 years (HR = 3.18 (2.1–4.9); p < 0.001) and a Charlson comorbidity score > 2 (1.91 (1.31–2.79); p = 0.003). Discontinuation of therapy was not significantly associated with a risk of death due to cardiovascular events. No risk factors responsible for re‐bleeding were identified, such as antiplatelet and anticoagulant therapy in particular.ConclusionsIn this cohort, the rates of mortality and DB re‐bleeding after a median follow‐up time of 3.9 years were 19.2% and 40.5%, respectively. The majority of the deaths recorded were not due to re‐bleeding.

Cookies & analyse de trafic

M ANDRE-JEAN REMY

Pourquoi vous devez consulter ce praticien

Thèses universitaires

Direction de thèses

Activité de recherche & publications

Publications académiques en France

Lieux de consultation(2)

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Top publications · les plus citées

Publications scientifiques (14) — classées par pathologie

Transversal7

Épidémiologie & registres2

Vraie vie / RWE2

Anti-TNF1

csDMARDs1

Gériatrie1

Pharmacovigilance1

Revue / méta-analyse1

Revue générale1

Partager cette fiche